| EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013 | 622 | 2013 |
| Safety and efficacy of botulinum toxin type A following long‐term use M Naumann, A Albanese, F Heinen, G Molenaers, M Relja European Journal of Neurology 13, 35-40, 2006 | 214 | 2006 |
| Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study N Klepac, V Trkulja, M Relja, T Babić European journal of neurology 15 (2), 128-133, 2008 | 195 | 2008 |
| Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects: A cross-sectional study N Klepac, M Relja, R Klepac, S Hećimović, T Babić, V Trkulja Journal of neurology 254, 1676-1683, 2007 | 192 | 2007 |
| A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic … M Relja, AC Poole, J Schoenen, J Pascual, X Lei, C Thompson Cephalalgia 27 (6), 492-503, 2007 | 151 | 2007 |
| Effect of Long‐Lasting Diabetes Mellitus on Rat and Human Brain Monoamines Z Lacković, M Šalković, Z Kuci, M Relja Journal of neurochemistry 54 (1), 143-147, 1990 | 146 | 1990 |
| Treatment of Tension-Type Headache by Injection of Botulinum toxin Type A: Double-blind placebo-Controlled Study M Relja, M Koršić American Academy of Neurology 51st Annual Meeting, A203, 1999 | 126 | 1999 |
| Botulinum toxin type A in experimental neuropathic pain L Bach-Rojecky, M Relja, Z Lacković Journal of neural transmission 112, 215-219, 2005 | 118 | 2005 |
| Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin MF Contarino, J Van Den Dool, Y Balash, K Bhatia, N Giladi, JH Koelman, ... Frontiers in neurology 8, 35, 2017 | 94 | 2017 |
| Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement A Albanese, G Abbruzzese, D Dressler, W Duzynski, S Khatkova, MJ Marti, ... Journal of neurology 262, 2201-2213, 2015 | 92 | 2015 |
| Botulinum toxin in tension-type headache M Relja, S Telarović Journal of neurology 251, i12-i14, 2004 | 84 | 2004 |
| Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy D Dressler, R Bhidayasiri, S Bohlega, P Chana, HF Chien, TM Chung, ... Journal of neurology 265, 856-862, 2018 | 83 | 2018 |
| Evidence for a widely distributed peripheral dopaminergic system. Z Lacković, M Relja Federation Proceedings 42 (13), 3000-3004, 1983 | 63 | 1983 |
| Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross‐sectional study in Croatia N Klepac, S Pikija, T Kraljić, M Relja, V Trkulja, S Juren, I Pavliček, ... European Journal of Neurology 14 (2), 194-198, 2007 | 62 | 2007 |
| Update on the management of Parkinson’s disease for general neurologists Z Pirtošek, O Bajenaru, N Kovács, I Milanov, M Relja, M Skorvanek Parkinson’s Disease 2020, 2020 | 53 | 2020 |
| Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity D Dressler, MC Altavista, E Altenmueller, R Bhidayasiri, S Bohlega, ... Journal of Neural Transmission 128, 321-335, 2021 | 50 | 2021 |
| Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission? Z Lacković, M Relja, NH Neff Journal of Neurochemistry 38 (5), 1453-1458, 1982 | 48 | 1982 |
| Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force D Dressler, R Bhidayasiri, S Bohlega, A Chahidi, TM Chung, M Ebke, ... Journal of neurology 264, 112-120, 2017 | 46 | 2017 |
| Strategies for treatment of dystonia D Dressler, E Altenmueller, R Bhidayasiri, S Bohlega, P Chana, ... Journal of neural transmission 123, 251-258, 2016 | 46 | 2016 |
| Treatment of tension-type headache with botulinum toxin: 1-year follow-up M Relja Headache World 2000, 336-336, 2000 | 41 | 2000 |
Pascual JCatedrático Universidad de Cantabria, Hospital Universitario Marques de Valdecilla, SantanderPotvrđena adresa e-pošte na humv.es
